a nonsignificant trendp value = 0.1154
Interestingly, patients who underwent immunotherapy as treatment for their primary cancer demonstrated a nonsignificant trend toward longer local progression-free survival ( p value = 0.1154, Fig. 5 d).
Interestingly, patients who underwent immunotherapy as treatment for their primary cancer demonstrated a nonsignificant trend toward longer local progression-free survival ( p value = 0.1154, Fig. 5 d).